Consumer
The company says 510(k) clearance will allow it to pursue multiple business opportunities pertaining to remote patient monitoring and clinical trials.
The patent includes the company's safety-focused LLMs incorporated into its Polaris constellation architecture.
The announcement comes about four months after Musk relayed his vision for patients with an Optimus robotic arm or leg to have the ability to control their limbs with the N1 implant.
The AI models only utilise wearable sleep and circadian rhythm data to analyse patterns driving mood disorders.
Health AI Developer Foundations is a suite of open-weight models publicly available to help developers build and implement AI models for health applications.
Jake Leach, executive VP and chief operating officer at Dexcom, joined MobiHealthNews to discuss the company's evolution and offerings beyond diabetes.
The aim is to provide long-term behavioral change focusing on weight loss and maintenance.
Ella is powered by Ema and functions as a personal-engagement platform where patients can learn from other patients with similar experiences.
Elon Musk's Neuralink gets greenlit by Health Canada to perform the first trial outside of the U.S. of its brain-computer implant and robot technology.
Members of the healthcare navigation and pharmacy benefits company will have access to Curai for virtual urgent care 24/7 via the Rightway app.